RNAC
Cartesian Therapeutics Inc.
8.00$
+2.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +97.7% | +34.5% | -97.4% | +336.2% | +639.4% | +148.6% | +412.6% | +30.2% | -76.5% | +49.6% | -92.8% | |
| – | -17.0% | +4.8% | +195.2% | +5.6% | -10.4% | – | – | – | -23.8% | – | – | |
| – | +97.7% | +34.5% | -97.4% | +336.2% | +639.4% | +148.6% | +412.6% | +27.8% | -76.1% | +49.6% | -92.8% | |
| – | +119.1% | +29.3% | +52.1% | +5.6% | -10.4% | +27.5% | +26.1% | +5.3% | -1.5% | -36.7% | +28.7% | |
| – | +4.8% | +56.6% | +44.2% | -3.1% | -10.1% | +15.4% | +10.7% | +14.0% | +69.5% | -25.5% | +4.5% | |
| – | +64.2% | +38.6% | +50.7% | +2.7% | -9.0% | +24.2% | +22.1% | +5.0% | +19.3% | -26.3% | +8.1% | |
| – | – | – | – | – | – | – | – | – | -694.4% | – | – | |
| – | +71.7% | +32.2% | -3.8% | +23.9% | +1.7% | +2.4% | +82.8% | +6.6% | -6.5% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | -786.5% | – | – | |
| – | +81.5% | -50.7% | -33.2% | -100.0% | +185,513,900.0% | -11.3% | +870.6% | -103.8% | – | – | -3,303.1% | |
| – | – | – | – | – | – | – | – | – | -721.0% | – | – | |
| – | – | – | – | – | – | – | – | – | -690.0% | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.